Reviews To Read – April 3, 2018.
from the Addiction Biology Unit
Quitting smoking is challenging. The recent development of varenicline (Chantix®) for smoking cessation is a successful story. In this article, we review the strong theoretical rationale, major findings in preclinical and clinical studies with varenicline, and post-market surveillance. We also discuss current major challenges and future research directions in medication development for smoking cessation.
Discovery and development of varenicline for smoking cessation. Journal Article
Expert Opin Drug Discov, pp. 1–12, 2018, ISSN: 1746-045X (Electronic); 1746-0441 (Linking).